RRAD and melanoma: The bio-distribution results of 99mTc-labeled RGD-Lys-(Arg11)CCMSH, RAD-Lys-(Arg11)CCMSH and RGD-Lys-(Arg11)CCMSHscramble in M21 human melanoma xenografts also strongly supported their peptide design.